Pricing Log in Create free account
Saturday 17 October 2026 Export TECH’s income statement to Excel — free account

Bio-Techne Corp

TECH Healthcare Biotechnology

Bio-Techne Corp’s revenue for fiscal 2026 (year ended June 2026) was $1.2 billion, roughly unchanged from fiscal 2025. In the quarter to June 2026, revenue grew 1.33%, EPS grew 418.2%, free cash flow fell 6.83% and total debt fell 42.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years.

72.54 0.02 +0.03%
Market cap
$11.4B
P/E
62.0×
Fwd P/E
37.6×
Dividend yield
0.44%
F-score
9/9
Altman Z
15.50
Beneish M
−2.52
Dividend safety
78/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Bio-Techne Corp (TECH) Gross margin

Alert me on Gross margin

Bio-Techne Corp's gross margin over the twelve months to 30 June 2026 was 65.8%. Over the past ten years it has ranged from 64.8% (fiscal 2025) to 68.4% (fiscal 2022); the current reading is higher than 25% of that period. That is in line with the Biotechnology industry median of 65.2% and above the Healthcare sector median of 53.5%.

Gross margin, annual

Embed this chart

Annual newest first

Period Gross margin Change (points)
FY2026 65.8% 0.97
FY2025 64.8% (1.61)
FY2024 66.4% (1.31)
FY2023 67.7% (0.70)
FY2022 68.4% 0.45
FY2021 68.0% 2.56
FY2020 65.4% (0.90)
FY2019 66.3% (0.90)
FY2018 67.2% 0.68
FY2017 66.5% (0.93)

Quarterly newest first

Period Gross margin Change (points)
Jun 2026 65.8% (1.06)
Mar 2026 66.9% 2.23
Dec 2025 64.7% (1.00)
Sep 2025 65.7% 2.93
42 more quarters

Against its own ten years

Low 64.8% High 68.4%
Ten-year median 66.9%
Current reading's percentile 21

Gross margin against peers

Company Gross margin
SMMT Summit Therapeutics PLC compare 100.0%
IBRX ImmunityBio, Inc. compare 99.3%
CORT Corcept Therapeutics Incorporated compare 98.3%
KRYS Krystal Biotech, Inc. compare 94.6%
BBIO BridgeBio Pharma, Inc. compare 94.4%
MDGL Madrigal Pharmaceuticals, Inc. compare 91.5%
BMRN BioMarin Pharmaceutical Inc. compare 76.1%
TECH Bio-Techne Corp 65.8%
PCVX Vaxcyte, Inc. compare 0.00%
Biotechnology industry median 65.2%
Healthcare sector median 53.5%
Market median 46.2%

What Gross margin is

Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.

Gross Profit ÷ Revenue

The full definition of Gross margin →

More on TECH